1. Daly A.K. and Idle J.R., Genetics: Animal and Human Cytochrome P450-Polymorphisms, in: Schenkman J.B. and Greim H. (eds.), Cytochrome P450, Handbook of Experimental Pharmacology, Springer, Berlin, Heidelberg: Springer, 105, 433–446, 1993
2. Doehmer J., V79 chinese hamster cells genetically engineered for cytochrome P450 and their use in mutagenicity and metabolism studies, Toxicology, 82, 105–118, 1993
3. Doehmer J., Strategies for the use of single cytochrome P450-enzymes in drug research and future prospects, in: Hildebrand M. and Waterman M. (eds.), Assessment of the Use of single Cytochrome P450-Enzymes in Drug Research, Berlin: Springer, 213–223, 1994
4. Fichtl B., Fülgraff G., Neumann H.-G., Wollenberg P., Forth W., Henschler D., Rummel W., Allgemeine Pharmakologie und Toxikologie, in: Forth W., Henschler D., Rummel W., Starke K. (Hrsg.), Allgemeine und spezielle Pharmakologie und Toxikologie, Mannheim, Wien: BI Wissenschaftsverlag, 1–95, 1992
5. Gieschen H., Hildebrand M., Salomon B., Metabolism of two dopaminergic ergot derivatives in genetically engineered V79-cells expressing CYP450-enzymes, in: Lechner M.C. (ed.), Cytochrome P450 Biochemistry, Biophysics and Molecular Biology, Paris: John Libbey Eurotext, 467, 1994